AstraZeneca PLC (AZN)
193.03
+5.87
(+3.14%)
USD |
NYSE |
Feb 06, 16:00
192.18
-0.85
(-0.44%)
Pre-Market: 08:40
AstraZeneca EPS Diluted (Quarterly) : 0.8063 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 0.414 |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0436 |
| Amgen, Inc. | 2.45 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.519B |
| Revenue (Quarterly) | 15.10B |
| Total Expenses (Quarterly) | 12.58B |
| Enterprise Value | 623.04B |
| Gross Profit Margin (Quarterly) | 73.89% |
| Profit Margin (Quarterly) | 16.69% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 2.11% |
| Normalized Earnings Yield | 1.592 |